: DEA spokesperson confirms it’s reviewing HHS recommendation for cannabis to be lowered to Schedule III from a Schedule I drug

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.

Best Stock Market Signals
Futures Trading
Stock Trading
Stock Trading Signals

Cart

: DEA spokesperson confirms it’s reviewing HHS recommendation for cannabis to be lowered to Schedule III from a Schedule I drug | Best Stock Trading Signals

admin

previous: December gold settles at $1,973/oz on Comex, up $7.90, or 0.4%

next: Middlefield Banc started at market perform at Raymond James

<div>Final S&P U.S. manufacturing index is 52.2 in February vs. initial 51.5</div>

Duolingo started at buy with $222 price target at Seaport

Home builders sentiment index rises in February to 48 vs forecast of 46